Serina Therapeutics (SER) Revenue (Gross) (2024 - 2025)
Serina Therapeutics' Revenue (Gross) history spans 2 years, with the latest figure at $68000.0 for Q2 2025.
- For Q2 2025, Revenue (Gross) rose 21.43% year-over-year to $68000.0; the TTM value through Sep 2025 reached $115000.0, down 19.58%, while the annual FY2024 figure was $235000.0, 16.96% down from the prior year.
- Revenue (Gross) for Q2 2025 was $68000.0 at Serina Therapeutics, up from $47000.0 in the prior quarter.
- Across five years, Revenue (Gross) topped out at $87000.0 in Q1 2024 and bottomed at $47000.0 in Q1 2025.